Company Encyclopedia
View More
name
HUAPONT LIFE SCIENCES
002004.SZ
Huapont Life Sciences Co.,Ltd. engages in the medicine, medical care, agrochemicals, new materials, tourism, and other businesses in China and internationally. The company is involved in the production and sale of pharmaceutical preparations and raw materials. It also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and cardiovascular, as well as health management products.
824.19 B
002004.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
D
Fertilizers and Agricultural ChemicalsIndustry
Industry Ranking53/63
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-1.40%D
    • Profit Margin-1.18%D
    • Gross Margin39.05%B
  • Growth ScoreD
    • Revenue YoY1.63%C
    • Net Profit YoY-155.84%E
    • Total Assets YoY-5.85%D
    • Net Assets YoY-2.16%D
  • Cash ScoreD
    • Cash Flow Margin-8509.58%E
    • OCF YoY1.63%C
  • Operating ScoreC
    • Turnover0.39C
  • Debt ScoreC
    • Gearing Ratio44.95%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    HUAPONT LIFE SCIENCES: The company has not yet engaged in the brain-computer interface business

    On October 30th, HUAPONT LIFE SCIENCES stated on the interactive platform that the company has not yet engaged in brain-computer interface business

    Zhitong·
    SZ
    002004
    +0.83%
    Zhitong·
    SZ
    002004
    +0.83%

    Innovative drug concept stocks continue to be active, HUAPONT LIFE SCIENCES hits the limit up

    Innovative drug concept stocks continue to be active, HUAPONT LIFE SCIENCES hits the limit up, Shen Lian Biomedical, Staidson BioPharm, CISEN, and WECOME follow suit

    Zhitong·
    SZ
    300683
    +0.99%
    SZ
    002004
    +0.83%
    SH
    688098
    +0.76%
    Zhitong·
    SZ
    300683
    +0.99%
    SZ
    002004
    +0.83%
    SH
    688098
    +0.76%

    HUAPONT LIFE SCIENCES' subsidiary has obtained the drug registration certificate for Mometasone Furoate Cream

    According to the Zhitong Finance APP, HUAPONT LIFE SCIENCES announced that its wholly-owned subsidiary Chongqing Huabong Pharmaceutical Co., Ltd. (referred to as "Huabong Pharmaceutical") recently received two specifications of the "Drug Registration Certificate" approved and issued by the National Medical Products Administration for Mometasone Furoate Cream. Mometasone Furoate Cream is mainly used for eczema, neurodermatitis, atopic dermatitis, and pruritus

    Zhitong·
    SZ
    002004
    +0.83%
    Zhitong·
    SZ
    002004
    +0.83%

    HUAPONT LIFE SCIENCES: Net profit of 388 million yuan in the first half of 2025, a year-on-year increase of 23.90%

    HUAPONT LIFE SCIENCES announced that in the first half of 2025, operating revenue was 5.945 billion yuan, a year-on-year increase of 0.39%. Net profit was 388 million yuan, a year-on-year increase of 23.90%. The company plans to distribute a cash dividend of 2 yuan for every 10 shares based on a total of 1.973 billion shares

    Zhitong·
    SZ
    002004
    +0.83%
    Zhitong·
    SZ
    002004
    +0.83%

    Shareholder of KS New Materials, HUAPONT LIFE SCIENCES, plans to inquire about the transfer of 4.75% of the company's shares

    According to the Zhitong Finance APP, KS New Materials has disclosed a shareholder inquiry transfer plan. The shareholder participating in the inquiry transfer is HUAPONT LIFE SCIENCES, and the total number of shares to be transferred is 20 million, accounting for 4.75% of the company's total share capital

    Zhitong·
    SZ
    301069
    +0.08%
    SZ
    002004
    +0.83%
    Zhitong·
    SZ
    301069
    +0.08%
    SZ
    002004
    +0.83%
    © 2025 Longbridge｜Disclaimer